BlackRock TCP Capital: The Bleeding Hasn't Stopped Yet — Negative

BLK   Seeking Alpha — June 02, 2025

TCPC remains a sell due to ongoing NAV decline, weak earnings, and lack of meaningful new investment activity despite some portfolio improvements. While the 14% dividend yield is well-covered and distributions are likely safe, long-term capital destruction outweighs the income appeal. Non-accruals have improved and management reduced expenses and debt, but persistent headwinds from high interest rates limit upside potential.

image for news BlackRock TCP Capital: The Bleeding Hasn't Stopped Yet

NEW YORK, NY / ACCESS Newswire / June 2, 2025 / If you suffered a loss on your Compass Group Diversified Holdings, LLC (NYSE:CODI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/compass-diversified-lawsuit-submission-form?prid=151301&wire=1&utm_campaign=4 or contact Joseph E. Levi, Esq.

image for news Compass Group Diversified Holdings, LLC (CODI) Lawsuit - Investors Urged to Contact Levi & Korsinsky Before July 8, 2025

NEW YORK, NY / ACCESS Newswire / June 2, 2025 / If you suffered a loss on your Krispy Kreme, Inc. (NASDAQ:DNUT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/krispy-kreme-inc-lawsuit-submission-form?prid=151302&wire=1&utm_campaign=17 or contact Joseph E. Levi, Esq.

image for news Class Action Alert: Levi & Korsinsky Reminds Krispy Kreme, Inc. (DNUT) Investors of July 15, 2025 Deadline

NEW YORK, June 02, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Savara Inc. (“Savara” or the “Company”) (NASDAQ: SVRA). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

image for news INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Savara Inc. - SVRA

IIPR holds more than $220 million in total liquidity, with a conservative 11% debt-to-assets ratio and sub-1x net debt-to-EBITDA. Tenant defaults led to a 13% QoQ AFFO drop to $55.3 million and a 6.5% revenue decline in Q1 FY 2025. The company re-leased ~1 million square feet in 18 months, replacing defaulted tenants with financially stronger operators.

image for news Innovative Industrial Properties: Where Capitulation Ends, Conviction Begins

SAN DIEGO, June 02, 2025 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP has launched an investigation into whether the board members of Blueprint Medicines Corporation (NASDAQ: BPMC) breached their fiduciary duties in connection with the proposed sale of the Company to Sanofi (NASDAQ: SNY).

image for news Johnson Fistel Investigates Fairness of Proposed Sale of Blueprint Medicines

Chinese cloud providers have been big buyers of U.S. artificial-intelligence hardware. Jefferies analysts are upbeat that the trend can continue despite trade-war pressures.

image for news China's AI industry is booming. Can Nvidia and other U.S. companies still get in on it?

JPMorgan CEO Jamie Dimon says his retirement is ‘several years away' — Negative

JPM   New York Post — June 02, 2025

JPMorgan CEO Jamie Dimon said his gig isn't up at America's largest bank on Monday, insisting in an exclusive interview with Fox Business that his retirement is “several years away.” The bank's succession planning has been under scrutiny on Wall Street in recent months as Dimon approaches two decades in the top job.

image for news JPMorgan CEO Jamie Dimon says his retirement is ‘several years away'

NEW YORK, June 02, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Organon & Co. (“Organon” or the “Company”) (NYSE: OGN). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

image for news INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Organon & Co. of Class Action Lawsuit and Upcoming Deadlines - OGN

NEW YORK, June 02, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of NeuroPace, Inc. (“NeuroPace” or the “Company”) (NASDAQ: NPCE). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

image for news INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of NeuroPace, Inc. - NPCE

GBOOY or BAM: Which Is the Better Value Stock Right Now? — Positive

BAM  GBOOY   Zacks Investment Research — June 02, 2025

Investors with an interest in Financial - Miscellaneous Services stocks have likely encountered both Grupo Financiero Banorte SAB de CV (GBOOY) and Brookfield Asset Management (BAM). But which of these two stocks is more attractive to value investors?

image for news GBOOY or BAM: Which Is the Better Value Stock Right Now?

GRFS vs. STVN: Which Stock Is the Better Value Option? — Neutral

GRFS  STVN   Zacks Investment Research — June 02, 2025

Investors looking for stocks in the Medical - Drugs sector might want to consider either Grifols (GRFS) or Stevanato Group (STVN). But which of these two stocks offers value investors a better bang for their buck right now?

image for news GRFS vs. STVN: Which Stock Is the Better Value Option?

ASAIY or K: Which Is the Better Value Stock Right Now? — Neutral

ASAIY  K   Zacks Investment Research — June 02, 2025

Investors interested in stocks from the Consumer Products - Discretionary sector have probably already heard of Sendas Distribuidora S.A. Sponsored ADR (ASAIY) and Kellanova (K).

image for news ASAIY or K: Which Is the Better Value Stock Right Now?

FLEX vs. GRMN: Which Stock Should Value Investors Buy Now? — Positive

FLEX  GRMN   Zacks Investment Research — June 02, 2025

Investors looking for stocks in the Electronics - Miscellaneous Products sector might want to consider either Flex (FLEX) or Garmin (GRMN). But which of these two stocks is more attractive to value investors?

image for news FLEX vs. GRMN: Which Stock Should Value Investors Buy Now?

TTEC vs. MLNK: Which Stock Is the Better Value Option? — Positive

MLNK  TTEC   Zacks Investment Research — June 02, 2025

Investors interested in stocks from the Technology Services sector have probably already heard of TTEC Holdings (TTEC) and MeridianLink (MLNK). But which of these two stocks is more attractive to value investors?

image for news TTEC vs. MLNK: Which Stock Is the Better Value Option?

CTTAY vs. RACE: Which Stock Is the Better Value Option? — Positive

CTTAY  RACE   Zacks Investment Research — June 02, 2025

Investors with an interest in Automotive - Original Equipment stocks have likely encountered both Continental AG (CTTAY) and Ferrari (RACE). But which of these two stocks is more attractive to value investors?

image for news CTTAY vs. RACE: Which Stock Is the Better Value Option?

CCU vs. SAM: Which Stock Is the Better Value Option? — Positive

CCU  SAM   Zacks Investment Research — June 02, 2025

Investors with an interest in Beverages - Alcohol stocks have likely encountered both Cervecerias Unidas (CCU) and Boston Beer (SAM). But which of these two stocks is more attractive to value investors?

image for news CCU vs. SAM: Which Stock Is the Better Value Option?

CRRFY vs. WMT: Which Stock Is the Better Value Option? — Positive

CRRFY  WMT   Zacks Investment Research — June 02, 2025

Investors interested in stocks from the Retail - Supermarkets sector have probably already heard of Carrefour SA (CRRFY) and Walmart (WMT). But which of these two stocks is more attractive to value investors?

image for news CRRFY vs. WMT: Which Stock Is the Better Value Option?

Why Novo Nordisk (NVO) is a Top Dividend Stock for Your Portfolio — Positive

NVO   Zacks Investment Research — June 02, 2025

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Novo Nordisk (NVO) have what it takes?

image for news Why Novo Nordisk (NVO) is a Top Dividend Stock for Your Portfolio

Are You Looking for a High-Growth Dividend Stock? — Positive

EFSC   Zacks Investment Research — June 02, 2025

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Enterprise Financial Services (EFSC) have what it takes?

image for news Are You Looking for a High-Growth Dividend Stock?